Lupus

The presence of mature red blood cells that still contain mitochondria is associated with higher systemic lupus erythematosus disease activity, according to data published in Cell.

Despite the ongoing setbacks presented by the COVID-19 pandemic, the Congress of Clinical Rheumatology – West will follow its East counterpart just a month later, offering a wholly new selection of “charismatic and engaging” speakers.

Among patients with arthritis, receiving exercise recommendations from a physician is “critical” to meeting physical activity guidelines and relieving symptom burden, regardless of race and ethnicity, researchers noted in BMC Public Health.

Patients with PTSD demonstrated a two-fold higher likelihood of being diagnosed with systemic lupus erythematosus, compared to those without PTSD, according to data published in Arthritis Care & Research.

About 29% of patients with systemic lupus erythematosus demonstrate low response to the COVID-19 vaccine, with immunosuppression therapy associated with decreased protection, according to data published in Arthritis & Rheumatology.

So-called “COVID toes” and other cutaneous manifestations of the virus are not the only dermatologic challenges that a rheumatologist may face, according to a presenter at the 2021 Congress of Clinical Rheumatology-East.

A thorough physical exam and attention to a patient’s medical history are integral to differentiating dermatomyositis from cutaneous dermatomyositis with similar features, according to a presenter here.

A mounting body of evidence is showing that cognitive dysfunction in lupus is a legitimate complaint, according to a presenter at the 2021 Congress of Clinical Rheumatology-East.

The FDA recently approved the first new drug for systemic lupus erythematosus since 2011. It was the top story in rheumatology last week.

The recent approval of anifrolumab highlights what may be a new wave of therapeutic advances made in lupus, according to a presenter at the 2021 Congress of Clinical Rheumatology-East.